The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, September 10, 2020
AstraZeneca Pharmaceuticals
A standard review process has been triggered, leading to the voluntary pause of all COVID-19 vaccination trials.
read more
Thursday, September 10, 2020
Early findings from researchers at CHOP show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-...
read more
Thursday, September 10, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Wednesday, September 09, 2020
Brickell has the right to develop AnGes’ proprietary investigational adjuvanted plasmid DNA vaccine intended to prevent COVID-19.
read more
Wednesday, September 09, 2020
Topline data showed no significant differences in the primary and secondary endpoints when comparing lenabasum to placebo, both added to background ...
read more
Wednesday, September 09, 2020
Athena announced the FDA has approved QDOLO Oral Solution, an opioid agonist indicated in adults for the management of pain severe enough to require ...
read more
Tuesday, September 08, 2020
Project ALS announced the FDA has granted orphan drug designation to prosetin for the treatment of ALS.
read more
Tuesday, September 08, 2020
Blueprint the FDA has approved GAVRETO for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer as detected ...
read more
Tuesday, September 08, 2020
Liminal BioSciences has filed a resubmission of the BLA for Ryplazim with the FDA for the treatment of congenital plasminogen deficiency.
read more
Monday, September 07, 2020
AbbVie and I-Mab have signed a collaboration agreement for the development and commercialization of lemzoparlimab, an anti-CD47 monoclonal antibody.
read more
Monday, September 07, 2020
The FDA has approved two additional doses of Eli Lilly and Company's Trulicity (dulaglutide).
read more
Monday, September 07, 2020
Sanofi and GSK have announced the start of the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine.
read more
Monday, September 07, 2020
Enesi Pharma has partnered with the University of Adelaide in Australia to develop a new vaccine against the Zika virus.
read more
Friday, September 04, 2020
LLS and PRA Health Sciences has announced a partnership to launch a global master clinical trial to develop new treatments for children with relapsed ...
read more
Friday, September 04, 2020
VistaGen Therapeutics announced positive new data from the Company's second preclinical study of its oral investigational drug, AV-101, in combination...
read more